p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization

Daniel K Fox1, Scott M Ebert1, Kale S Bongers1

  • 1Departments of Internal Medicine and Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa; and.

Insights

Immobilization causes muscle atrophy through p53 and ATF4. These factors, along with p21, are key mediators of muscle wasting, with p21 being essential for atrophy.

Area of Science:

  • Muscle physiology and molecular biology
  • Cellular stress response pathways
  • Skeletal muscle atrophy research

Background:

  • Immobilization leads to skeletal muscle atrophy through poorly understood signaling pathways.
  • Transcription factors p53 and ATF4 are involved in cellular stress adaptation.

Purpose of the Study:

  • To investigate the roles of p53 and ATF4 in immobilization-induced skeletal muscle atrophy.
  • To identify downstream effectors of p53 and ATF4 in muscle atrophy.

Main Methods:

  • Utilized mouse models with muscle immobilization.
  • Analyzed gene expression of p53, ATF4, and p21 in muscle fibers.
  • Employed genome-wide mRNA expression arrays.

Main Results:

  • Muscle immobilization increased p53 and ATF4 expression, causing atrophy.
  • Muscle fibers lacking p53 or ATF4 showed partial resistance to atrophy.
  • p53 and ATF4 acted independently and additively, with combined expression causing greater atrophy.
  • p21 was identified as a critical downstream effector, essential for atrophy induced by immobilization, p53, and ATF4.

Conclusions:

  • p53 and ATF4 are essential and complementary mediators of immobilization-induced muscle atrophy.
  • p21 is a critical downstream effector of the p53 and ATF4 pathways in muscle atrophy.
  • Understanding these pathways offers potential therapeutic targets for muscle wasting conditions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K